Cybersecurity roundup: U.S. to ban Kaspersky antivirus; Cost of healthcare breaches way up

The White House this past week announced its plans to ban new sales of antivirus software from Kaspersky Lab, after years of pushback against the Russia-based company, and fears that its tools themselves pose a security risk to critical U.S. infrastructure, including healthcare.

The Biden Administration alleges that Kaspersky's privileged access to American IT systems – it's installed on computers used by healthcare organizations, state government agencies and elsewhere – could enable it to exfiltrate important data or to stealthily …

administration antivirus antivirus software ban biden biden administration breaches cost critical cybersecurity healthcare house infrastructure kaspersky kaspersky lab lab plans risk roundup russia russia-based sales security security risk software tools week white house